Table 2.
Evidence for secreted factors in resistance to mucosal human immunodeficiency virus (HIV)-1 infection
| Exposure route | Cohort types | Cohort definition | Immune-mediated mechanism(s) and references |
|---|---|---|---|
| Sexual exposure (male/female) | •Discordant couples | Individuals exposed to HIV-1 via unprotected vaginal intercourse with an HIV-infected person | Mucosal or systemic IgA [5,44–48,52,58–60]CC (β)-chemokines [64,65,67] |
| •Sex workers | SLP1, lactoferrin, elafin/trappin-2 [73,74] | ||
| Defensins [79–81] | |||
| Sexual exposure (male/male) | •Discordant couples | Individuals exposed to HIV-1 via unprotected anal intercourse with an HIV-infected person | Mucosal or systemic IgA [49,50] |
| CC (β)-chemokines [66] | |||
| Mother-to-child exposure | •Vertical transmission | Children exposed to HIV-1 through carriage from HIV-1-infected mother | Mucosal or systemic IgA [51] |
| Defensins [76,82] | |||
| Oral exposure | •Breastfeeding | Children exposed to HIV-1 through nursing.Sexually active adults | Mucosal or systemic IgA [49,50,51] |
| •Discordant couples (oral sex) | CC (β)-chemokines [66] | ||
Ig, immunoglobulin.